The expanding importance of tissue sample analysis for biomarker testing in non-small cell lung cancer management and survival

The expanding importance of tissue sample analysis for biomarker testing in non-small cell lung cancer management and survival

Non-small-cell lung cancer (NSCLC) is the most frequent type of lung cancer, currently a leading cause of cancer-related death worldwide. The development of molecular biomarkers has led to novel treatment strategies and subsequent improvement in survival outcomes in all stages of the disease. ...

Full description

Bibliographic Details
Main Authors:	Augusto Valdivia, Ilaria Priano, Nuria Pardo, Enriqueta Felip
Format:	Article
Language:	English
Published:	Publicaciones Permanyer 2024-01-01
Series:	Barcelona Respiratory Network Reviews
Subjects:	Biomarkers. Immunotherapy. Non-small-cell lung cancer. Targeted therapy.
Online Access:	https://www.brnreviews.com/frame_eng.php?id=245

Similar Items

Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy
by: Susana Cedres, et al.
Published: (2023-12-01)

The advances in immunotherapy biomarkers of small cell lung cancer
by: XIE Mengqing, CHU Xiangling, ZHOU Juan, SU Chunxia
Published: (2021-07-01)

Liquid biomarkers in melanoma: detection and discovery
by: Su Yin Lim, et al.
Published: (2018-01-01)

Gastric Cancer: Mechanisms, Biomarkers, and Therapeutic Approaches
by: Sangjoon Choi, et al.
Published: (2022-02-01)

Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy
by: Zachary J. Brown, et al.
Published: (2022-03-01)

Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer
by: Sonam Puri, et al.
Published: (2020-11-01)

Biomarker-Targeted Therapies in Non–Small Cell Lung Cancer: Current Status and Perspectives
by: Haiyang Guo, et al.
Published: (2022-10-01)

Blood Biomarkers of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
by: Yolanda Lage Alfranca, et al.
Published: (2022-06-01)

The expanding scenario of advanced non-small-cell lung cancer between emerging evidence and clinical tasks
by: Andrea De Giglio, et al.
Published: (2023-05-01)

Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer
by: Max Hardy-Werbin, et al.
Published: (2019-06-01)

Novel Biomarkers and Druggable Targets in Advanced Melanoma
by: Pier Francesco Ferrucci, et al.
Published: (2021-12-01)

Important clinical research progress in lung cancer in 2022
by: SU Chunxia, ZHOU Caicun
Published: (2023-03-01)

Hypoalbuminaemia as a Prognostic Biomarker of First-Line Treatment Resistance in Metastatic Non-small Cell Lung Cancer
by: Mark Stares, et al.
Published: (2021-10-01)

Research Progress on Efficacy-related Biomarkers of Immunotherapy in Non-small Cell Lung Cancer
by: ZHENG Jianhong, et al.
Published: (2024-02-01)

Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients
by: Susana Cedres, et al.
Published: (2023-07-01)

A Combination of Biomarkers Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
by: Zedong Jiang, et al.
Published: (2021-12-01)

Immunotherapy Advances in Small Cell Lung Cancer
by: Yangyang XU, et al.
Published: (2020-11-01)

Small Cell Lung Carcinoma: Current Diagnosis, Biomarkers, and Treatment Options with Future Perspectives
by: Kristina Krpina, et al.
Published: (2023-07-01)

Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment
by: Jingtao Chen, et al.
Published: (2023-03-01)

Human fibronectin extra domain B as a biomarker for targeted therapy in cancer
by: Relinde I. Y. Lieverse, et al.
Published: (2020-07-01)

Bladder Cancer Tissue-Based Biomarkers
by: Francesco Soria, Marta Sanchez-Carbayo, Natalya Benderska-Söder , Bernd J Schmidz-Dräger, Stefania Zamboni, Marco Moschini, Anirban P Mitra, Yair Lotan
Published: (2021-01-01)

Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer
by: Carmine D'Aniello, et al.
Published: (2019-12-01)

Advances in Biomarkers for Immunotherapy of Non-small Cell Lung Cancer
by: Chuan HUANG, et al.
Published: (2021-11-01)

Efficacy of natural killer cell activity as a biomarker for predicting immunotherapy response in non‐small cell lung cancer
by: Myeong Geun Choi, et al.
Published: (2020-11-01)

Senescent T cells: a potential biomarker and target for cancer therapy
by: Jie Zhang, et al.
Published: (2021-06-01)

Systemic therapies in hepatocellular carcinoma: Existing and emerging biomarkers for treatment response
by: Penghui He, et al.
Published: (2022-11-01)

Present and Emerging Biomarkers in Immunotherapy for Metastatic Non-Small Cell Lung Cancer: A Review
by: Raida M. Khwaja, et al.
Published: (2022-01-01)

The Importance of <i>STK11</i>/<i>LKB1</i> Assessment in Non-Small Cell Lung Carcinomas
by: Baharia Mograbi, et al.
Published: (2021-01-01)

Identifying High-Risk Tumors within AJCC Stage IB–III Melanomas Using a Seven-Marker Immunohistochemical Signature
by: Robin Reschke, et al.
Published: (2021-06-01)

Emerging therapies for small cell lung cancer
by: Sen Yang, et al.
Published: (2019-05-01)

Identification of CXCL5 expression as a predictive biomarker associated with response and prognosis of immunotherapy in patients with non‐small cell lung cancer
by: Jie Deng, et al.
Published: (2022-04-01)

Advances and Therapeutic Perspectives in Extended-Stage Small-Cell Lung Cancer
by: Thomas Pierret, et al.
Published: (2020-11-01)

Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients
by: Ana Callejo, et al.
Published: (2021-06-01)

Case Report: Long Progression-Free Survival of Immunotherapy for Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation
by: Jianfeng Peng, et al.
Published: (2021-09-01)

Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers
by: Xabier Mielgo-Rubio, et al.
Published: (2020-11-01)

Serum cytokine levels and other associated factors as possible immunotherapeutic targets and prognostic indicators for lung cancer
by: Yinghao Zhao, et al.
Published: (2023-02-01)

Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening
by: Yijun Wu, et al.
Published: (2023-09-01)

Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma
by: Gok Yavuz B, et al.
Published: (2021-09-01)

Imaging Biomarkers to Predict and Evaluate the Effectiveness of Immunotherapy in Advanced Non-Small-Cell Lung Cancer
by: Ying Liu, et al.
Published: (2021-03-01)

Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study
by: Sevinj Yolchuyeva, PhD, et al.
Published: (2023-12-01)